Eden Research plc, a leading UK agrochemical development company, is pleased to announce that it has entered into a data sharing arrangement with DSM Nutraceuticals Limited ("DSM").
Under this agreement, Eden has provided DSM with rights to certain data acquired as part of its EU dossier to support the pesticidal registration of Thymol, which is one of the active substances currently in the EU approval process for Annex I inclusion and a component of 3-AEY, Eden's botrytis product. The agreement allows DSM to use the data to support the registration of its nutraceutical products and is for a consideration of £34,000.
DSM, which is based in Kaiseraugst, Switzerland, is involved in the improvement in performance of animal and human health products.
Clive Newitt, Managing Director of Eden Research, said:
"Whilst this agreement covers markets which are clearly not core activities of Eden, it demonstrates how we are maximising the value of all of the intellectual property that the Company has developed. This marks further progress with this project and we are continuing actively to seek out further opportunities to maximise the return on the core data packages we have invested in."
The directors of Eden Research Plc are responsible for the contents of this announcement.
Enquiries:
Eden Research plc
Clive Newitt, Managing Director
01993 862761
St Helens Capital Partners LLP
Mark Anwyl or Duncan Vasey
020 7368 6959
Threadneedle Communications
Josh Royston
Beth Harris
020 7653 9850